Abstract No. 513 Optimizing Patient Selection for Combined TACE and Targeted Therapy in HCC: A Systematic Review and Meta-Analysis
Inconsistent results from randomized controlled trials (RCTs) on combined transarterial chemoembolization (TACE) and targeted therapy for hepatocellular carcinoma (HCC) have led to uncertainty in patient selection and treatment efficacy. This study aimed to determine the efficacy of combined TACE and targeted therapy in HCC and identify key prognostic factors influencing outcomes to improve patient selection.
vigna
0
0
Inconsistent results from randomized controlled trials (RCTs) on combined transarterial chemoembolization (TACE) and targeted therapy for hepatocellular carcinoma (HCC) have led to uncertainty in patient selection and treatment efficacy. This study aimed to determine the efficacy of combined TACE and targeted therapy in HCC and identify key prognostic factors influencing outcomes to improve patient selection.
